Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37CA011898-26
Application #
2086002
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1976-12-01
Project End
2001-03-31
Budget Start
1996-04-10
Budget End
1997-03-31
Support Year
26
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Koroukian, Siran M; Bakaki, Paul M; Golchin, Negar et al. (2015) Breast Cancer Stage and Treatment Among Ohio Medicaid Beneficiaries With and Without Mental Illness. J Oncol Pract 11:e50-8
Chandramohan, Vidyalakshmi; Mitchell, Duane A; Johnson, Laura A et al. (2013) Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors. Future Oncol 9:977-90
Chandramohan, Vidyalakshmi; Bao, Xuhui; Keir, Stephen T et al. (2013) Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy. Clin Cancer Res 19:4717-27
Piao, Hailan; Kuan, Chien-Tsun; Chandramohan, Vidya et al. (2013) Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas. MAbs 5:748-62
Chandramohan, Vidyalakshmi; Bao, Xuhui; Kato Kaneko, Mika et al. (2013) Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. Int J Cancer 132:2339-48
Reardon, David A; Norden, Andrew D; Desjardins, Annick et al. (2012) Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. J Neurooncol 106:409-15
Zalutsky, Michael R; Boskovitz, Abraham; Kuan, Chien-Tsun et al. (2012) Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors. Nucl Med Biol 39:23-34
Koroukian, Siran M; Bakaki, Paul M; Golchin, Negar et al. (2012) Mental illness and use of screening mammography among Medicaid beneficiaries. Am J Prev Med 42:606-9
Reardon, David A; Desjardins, Annick; Peters, Katherine B et al. (2012) Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma. J Neurooncol 107:155-64
Reardon, David A; Desjardins, Annick; Vredenburgh, James J et al. (2012) Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer 118:4759-67

Showing the most recent 10 out of 267 publications